Cargando…

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis

BACKGROUND: Neuroleptic malignant syndrome (NMS) is a rare, severe, idiosyncratic adverse reaction to antipsychotics. Second-generation antipsychotics (SGAs) were originally assumed to be free from the risk of causing NMS, however several cases of NMS induced by SGAs (SGA-NMS) have been reported. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belvederi Murri, Martino, Guaglianone, Argentina, Bugliani, Michele, Calcagno, Pietro, Respino, Matteo, Serafini, Gianluca, Innamorati, Marco, Pompili, Maurizio, Amore, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359181/ https://www.ncbi.nlm.nih.gov/pubmed/25578944 http://dx.doi.org/10.1007/s40268-014-0078-0

Ejemplares similares

Physical Exercise in Major Depression: Reducing the Mortality Gap While Improving Clinical Outcomes
por: Belvederi Murri, Martino, et al.
Publicado: (2019)

The Relationship between Childhood Maltreatment and Non-Suicidal Self-Injury: A Systematic Review
por: Serafini, Gianluca, et al.
Publicado: (2017)

Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
por: Korchia, Théo, et al.
Publicado: (2018)

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription
por: Reilly, Thomas J, et al.
Publicado: (2017)

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon
por: Hirjak, Dusan, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics
por: Ramadas, Smitha, et al.
Publicado: (2022)

The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome
por: Kyotani, Yoji, et al.
Publicado: (2023)

Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal
por: Maeda, Keisuke, et al.
Publicado: (2023)

An Unusual Case of Neuroleptic Malignant Syndrome on a Stable Dose of Antipsychotic
por: Sanger, Emily, et al.
Publicado: (2023)

Neuroleptic malignant syndrome associated with second-generation antipsychotics (SGA): An analysis of reported cases in eudravigilance database, 2017-2020
por: Torres, A., et al.
Publicado: (2021)

A Case of Catatonia and Neuroleptic Malignant Syndrome Probably Associated with Antipsychotic in Korea
por: Choi, Ho-Dong, et al.
Publicado: (2011)

Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013)

Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene
por: Ngo, Vivian, et al.
Publicado: (2019)

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study
por: Innamorati, Marco, et al.
Publicado: (2013)

Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating Overview
por: Pompili, Maurizio, et al.
Publicado: (2016)

The Association between Cannabis Use, Mental Illness, and Suicidal Behavior: What is the Role of Hopelessness?
por: Serafini, Gianluca, et al.
Publicado: (2013)

Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
por: Park, Jong-Il, et al.
Publicado: (2019)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
por: Hirofuji, Sakiko, et al.
Publicado: (2023)

“Surrounded, detached”: the relationship between defensive peripersonal space and personality
por: Biggio, Monica, et al.
Publicado: (2023)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient
por: Espiridion, Eduardo D, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndrome
por: Hara, Yoshiki, et al.
Publicado: (2016)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

Understanding Suicidal Behavior: The Contribution of Recent Resting-State fMRI Techniques
por: Serafini, Gianluca, et al.
Publicado: (2016)

The impact of white matter hyperintensities on the structural connectome in late-life depression: Relationship to executive functions
por: Respino, Matteo, et al.
Publicado: (2019)

Cognitive Vulnerabilities and Depression in Young Adults: An ROC Curves Analysis
por: Balsamo, Michela, et al.
Publicado: (2013)

Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report
por: Langan, Julie, et al.
Publicado: (2012)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics
por: Pompili, Maurizio
Publicado: (2020)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Corrigendum: Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics
por: Pompili, Maurizio
Publicado: (2020)

Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003)

Resolution of symptoms in neuroleptic malignant syndrome
por: Pereira, Yvonne D.S., et al.
Publicado: (2010)

Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)

Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_toqailm520a8serlnr49b03d16